Literature DB >> 18310711

Simulated joint infection assessment by rapid detection of live bacteria with real-time reverse transcription polymerase chain reaction.

Patrick Birmingham1, Jeannine M Helm, Paul A Manner, Rocky S Tuan.   

Abstract

BACKGROUND: Although microbiological bacterial culture is currently considered the gold standard for diagnosis of septic arthritis, many studies have documented substantial false-negative and false-positive rates. The objective of this study was to determine whether real-time quantitative reverse transcription polymerase chain reaction can be used to detect bacterial messenger RNA (mRNA) in synovial fluid as a way to distinguish live and dead bacteria as an indicator of active infection.
METHODS: Synovial fluid samples were obtained from twelve consecutive patients who presented with knee pain and effusion but no evidence of infection. Following assurance of sterility with plate cultures, each sample was inoculated with clinically relevant bacteria and incubated for twenty-four hours to simulate septic arthritis. Bacterial viability and load were assessed with cultures. Selected samples were also treated with a single dose of a combination of two antibiotics, vancomycin and gentamicin, and sampled at several time points. Total RNA isolated from each sample was analyzed in triplicate with one-step real-time quantitative reverse transcription polymerase chain reaction to detect mRNA encoding for the genes groEL or femC. Controls included sterile, uninoculated samples and inoculated samples analyzed with quantitative polymerase chain reaction without reverse transcription. mRNA content was estimated on the basis of detection limits as a function of serial dilutions and was expressed as a function of colony number in bacterial cultures and RNA content as determined spectrophotometrically.
RESULTS: All synovial fluid samples that had been inoculated with one of the four bacterial species, and analyzed in triplicate, were identified (distinguished from aseptic synovial fluid) with real-time quantitative reverse transcription polymerase chain reaction; there were no false-negative results. All inoculated samples produced bacterial colonies on culture plates, while cultures of the aseptic samples were negative for growth. The detection limit of the one-step bacterial mRNA-based real-time quantitative reverse transcription polymerase chain reaction varied depending on the bacterial species. A time-dependent decrease in the concentration of detectable bacterial mRNA was seen after incubation of bacteria with antibiotics.
CONCLUSIONS: The direct quantification of the concentration of viable bacterial mRNA with real-time quantitative reverse transcription polymerase chain reaction allows identification of both culture-positive bacterial infection and so-called unculturable bacterial infection in a simulated septic arthritis model. In contrast to conventional polymerase chain reaction, real-time quantitative reverse transcription polymerase chain reaction minimizes false-positive detection of nonviable bacteria and thus provides relevant information on the success or failure of antibiotic therapy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18310711     DOI: 10.2106/JBJS.G.00348

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  13 in total

Review 1.  [Molecular pathological diagnostics of infections in orthopedic pathology].

Authors:  J Kriegsmann; N Arens; C Altmann; M Kriegsmann; R Casadonte; M Otto
Journal:  Pathologe       Date:  2014-11       Impact factor: 1.011

Review 2.  Current concepts review: septic arthritis of the knee pathophysiology, diagnostics, and therapy.

Authors:  Atesch Ateschrang; Dirk Albrecht; Steffen Schroeter; Kuno Weise; Jürgen Dolderer
Journal:  Wien Klin Wochenschr       Date:  2011-04-06       Impact factor: 1.704

3.  Detection of periprosthetic infections with use of ribosomal RNA-based polymerase chain reaction.

Authors:  Patrick F Bergin; Jason D Doppelt; William G Hamilton; Gudrun E Mirick; Angela E Jones; Supatra Sritulanondha; Jeannine M Helm; Rocky S Tuan
Journal:  J Bone Joint Surg Am       Date:  2010-03       Impact factor: 5.284

4.  Molecular diagnostics.

Authors:  Hyonmin Choe; Carl A Deirmengian; Noreen J Hickok; Tiffany N Morrison; Rocky S Tuan
Journal:  J Am Acad Orthop Surg       Date:  2015-04       Impact factor: 3.020

5.  Revision total knee arthroplasty infection: incidence and predictors.

Authors:  S M Javad Mortazavi; Justin Schwartzenberger; Matthew S Austin; James J Purtill; Javad Parvizi
Journal:  Clin Orthop Relat Res       Date:  2010-08       Impact factor: 4.176

Review 6.  [Applications of molecular pathology in the diagnosis of joint infections].

Authors:  J Kriegsmann; T Hopf; D Jacobs; N Arens; V Krenn; R Schmitt-Wiedhoff; M Kriegsmann; C Heisel; C Biehl; H Thabe; R P H Schmitz; M Lehmann; M Otto
Journal:  Orthopade       Date:  2009-06       Impact factor: 1.087

7.  Detecting the Presence of Bacterial DNA and RNA by Polymerase Chain Reaction to Diagnose Suspected Periprosthetic Joint Infection after Antibiotic Therapy.

Authors:  Xin-Yu Fang; Wen-Bo Li; Chao-Fan Zhang; Zi-da Huang; Hui-Yi Zeng; Zheng Dong; Wen-Ming Zhang
Journal:  Orthop Surg       Date:  2018-01-30       Impact factor: 2.071

8.  Arthroscopic treatment for acute septic arthritis of the hip joint in adults.

Authors:  Young-Kyun Lee; Kyung-Sun Park; Yong-Chan Ha; Kyung-Hoi Koo
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2012-11-01       Impact factor: 4.342

9.  Polymerase Chain Reaction molecular diagnostic technology for monitoring chronic osteomyelitis.

Authors:  Brian D Mariani; Daniel S Martin; Antonia F Chen; Haruyo Yagi; Sheldon S Lin; Rocky S Tuan
Journal:  J Exp Orthop       Date:  2014-08-15

10.  Dual therapeutic targeting of intra-articular inflammation and intracellular bacteria enhances chondroprotection in septic arthritis.

Authors:  Hyuk-Kwon Kwon; Inkyu Lee; Kristin E Yu; Sean V Cahill; Kareme D Alder; Saelim Lee; Christopher M Dussik; JungHo Back; Jeongjoon Choi; Lee Song; Themis R Kyriakides; Francis Y Lee
Journal:  Sci Adv       Date:  2021-06-25       Impact factor: 14.957

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.